Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sara Viksmoen Watle

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Vaccine|August 30, 2023
Antibodies against Neisseria meningitidis serogroups A, C, W and Y in serum and saliva of Norwegian adolescentsSara Viksmoen Watle, Bente Børud, Ida Laake, et al.
Public Health in Practice (Oxford, England)|September 1, 2021
Relationship between teaching modality and COVID-19, well-being, and teaching satisfaction (campus & corona): A cohort study among students in higher educationAtle Fretheim, Arnfinn Helleve, Borghild Løyland, et al.
BMC Medicine|September 1, 2022
Age and product dependent vaccine effectiveness against SARS-CoV-2 infection and hospitalisation among adults in Norway: a national cohort study, July-November 2021Jostein Starrfelt, Anders Skyrud Danielsen, Eirik Alnes Buanes, et al.
Vaccine|November 14, 2022
Short-term safety of COVID-19 mRNA vaccines with respect to all-cause mortality in the older population in NorwayPaz Lopez-Doriga Ruiz, Nina Gunnes, Jon Michael Gran, et al.
BMJ (Clinical Research Ed.)|May 6, 2021
Arterial events, venous thromboembolism, thrombocytopenia, and bleeding after vaccination with Oxford-AstraZeneca ChAdOx1-S in Denmark and Norway: population based cohort studyAnton Pottegård, Lars Christian Lund, Øystein Karlstad, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|December 17, 2021
Outbreak caused by the SARS-CoV-2 Omicron variant in Norway, November to December 2021Lin T Brandal, Emily MacDonald, Lamprini Veneti, et al.
Open Heart|May 4, 2026
Myocarditis after COVID-19 mRNA vaccination in Norway: a nationwide validation studyBendik Skinningsrud Hagen, Katarina Vlaisavljevic, Lars Sandve Oppedal, et al.
Lancet (London, England)|December 27, 2016
Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola Ça Suffit!)Ana Maria Henao-Restrepo, Anton Camacho, Ira M Longini, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Vaccine|August 30, 2023
Antibodies against Neisseria meningitidis serogroups A, C, W and Y in serum and saliva of Norwegian adolescentsSara Viksmoen Watle, Bente Børud, Ida Laake, et al.
Public Health in Practice (Oxford, England)|September 1, 2021
Relationship between teaching modality and COVID-19, well-being, and teaching satisfaction (campus & corona): A cohort study among students in higher educationAtle Fretheim, Arnfinn Helleve, Borghild Løyland, et al.
BMC Medicine|September 1, 2022
Age and product dependent vaccine effectiveness against SARS-CoV-2 infection and hospitalisation among adults in Norway: a national cohort study, July-November 2021Jostein Starrfelt, Anders Skyrud Danielsen, Eirik Alnes Buanes, et al.
Vaccine|November 14, 2022
Short-term safety of COVID-19 mRNA vaccines with respect to all-cause mortality in the older population in NorwayPaz Lopez-Doriga Ruiz, Nina Gunnes, Jon Michael Gran, et al.
BMJ (Clinical Research Ed.)|May 6, 2021
Arterial events, venous thromboembolism, thrombocytopenia, and bleeding after vaccination with Oxford-AstraZeneca ChAdOx1-S in Denmark and Norway: population based cohort studyAnton Pottegård, Lars Christian Lund, Øystein Karlstad, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|December 17, 2021
Outbreak caused by the SARS-CoV-2 Omicron variant in Norway, November to December 2021Lin T Brandal, Emily MacDonald, Lamprini Veneti, et al.
Open Heart|May 4, 2026
Myocarditis after COVID-19 mRNA vaccination in Norway: a nationwide validation studyBendik Skinningsrud Hagen, Katarina Vlaisavljevic, Lars Sandve Oppedal, et al.
Lancet (London, England)|December 27, 2016
Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola Ça Suffit!)Ana Maria Henao-Restrepo, Anton Camacho, Ira M Longini, et al.
Pageof 2